BOF vs GROV
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals critical weaknesses in BOF's financial health, highlighted by a Piotroski F-Score of 0/9, indicating severe operational and financial distress. Despite a strong year-over-year revenue growth of 47.60% and a current ratio above 1.6, the company is deeply unprofitable with a profit margin of -49.75% and an alarming ROE of -168.18%. Valuation multiples like Price/Book of 7.18 and Price/Sales of 3.58 appear stretched given the lack of earnings, negative cash flow, and absence of a calculable Altman Z-Score, which raises concerns about solvency. While insider sentiment is moderately positive at 40/100, it does not offset the overwhelming financial instability and weak technical trend of 0/100.
GROV exhibits severe financial distress, anchored by a critical Piotroski F-Score of 1/9 and a negative Price-to-Book ratio of -2.68, indicating negative shareholders' equity. While the company has recently beaten lowered earnings estimates, it continues to operate at a loss with shrinking revenue (-14.3% YoY). The catastrophic 5-year price decline of 97.8% and a low Quick Ratio of 0.31 suggest a high risk of insolvency or further dilution. The lack of a Graham Number or Intrinsic Value calculation is a direct result of the company's negative equity and earnings profile.
Compare Another Pair
Related Comparisons
BOF vs GROV: Head-to-Head Comparison
This page compares BranchOut Food Inc. (BOF) and Grove Collaborative Holdings, Inc. (GROV) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.